Proliferative potential of recurrent intracranial meningiomas as evaluated by labelling indices of BUdR and Ki-67, and tumour doubling time

Acta Neurochirurgica

Volumn 140, Issue 1, 1998, Pages 26-32

  Kakinuma, K ^a   Tanaka, R ^a   Onda, K ^a   Takahashi, H ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Bromodeoxyuridine; Ki 67; Recurrent meningioma; Tumour doubling time

Indexed keywords

BROXURIDINE; MONOCLONAL ANTIBODY KI 67;

ADULT; ARTICLE; COMPUTER PROGRAM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; PRIORITY JOURNAL; RECURRENT CANCER; REGRESSION ANALYSIS; TUMOR GROWTH;

ADULT; BROMODEOXYURIDINE; CELL DIVISION; FEMALE; HUMANS; KI-67 ANTIGEN; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL;

EID: 0031982730     PISSN: 00016268     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007010050053     Document Type: Article

References (25)

1. Alarez F, Roda JM, Romero MP, Morales C, Sarmiento MA, Blazqueze MG (1987) Malignant and atypical meningiomas: a reappraisal of clinical, histological, and computed tomographic features. Neurosurgery 205: 688-694
2. Al-Mefty O, Kersh JE, Routh A, Smith RR (1990) The longtime side effects of radiation therapy for benign brain tumour in adults. J Neurosurg 73: 502-512
3. Barbaro NM, Gutin PH, Wilson CB, Sheline GE, Boldrey EB, Wara WM (1987) Radiation therapy in the treatment of partially resected meningiomas. Neurosurgery 20: 525-528
4. Carella RJ, Ransohoff J, Newall J (1982) Role of radiation therapy in the management of meningioma. Neurosurgery 10: 332-339
5. Cho KG, Hoshino T, Nagashima T, Murovic JA, Wilson CB (1986) Predication of tumour doubling time in recurrent meningiomas. Cell kinetics studies with bromodeoxyuridine labeling. J Neurosurg 65: 790-794
6. Fukui M, Iwaki T, Sawa H, Kitayama K (1986) Proliferative activity of meningiomas as evaluated by bromodeoxyuridine uptake examination. Acta Neurochir (Wien) 81: 135-141
7. Firsching RP, Fischer A, Peters R, Thun F, Klug N (1990) Growth rate of incidental meningiomas. J Neurosurg 73: 545-547
8. Goldsmith BJ, Wara WM, Wilson CB, Larson DA (1994) Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 80: 195-201
9. Hoshino T, Nagashima T, Murovic JA, Wilson CB, Davis RL (1986) Proliferative potential of human meningiomas of the brain. A cell kinetics study with bromodeoxyuridine. Cancer 58: 1466-1492
10. Jääskeläinen J, Haltia M, Lassonen E, Wahlström T, Valtonen S (1985) The growth rate of intracranial meningiomas and its relation to histology. An analysis of 43 patients. Surg Neurol 24: 165-172
11. Jääskeläinen J, Haltia M, Servo A (1986) Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol 25: 232-242
12. Karamitopoulou E, Perentes E, Diamantis I, Maraziotis T (1994) Ki-67 immunoreactivity in human central nervous system tumours: a study with MIB 1 monoclonal antibody on archival material. Acta Neuropathol 87: 47-54
13. Lee KS, Hoshino T, Rodrigeuz LA, Bederson J, Davis RL, Wilson CB (1990) Bromodeoxyuridine labeling study of intracranial meningiomas: proliferative potential and recurrence. Acta Neuropathol 80: 311-317
14. Maier H, Öfner D, Hittmair A, Kitz K, Budka H (1992) Classic, atypical, and anaplastic meningioma: three histological subtypes of clinical relevance. J Neurosurg 77: 616-623
15. May PI, Broome JC, Lawry J, Buxton RA, Battersby RDE (1989) The prediction of recurrent meningiomas. A flow cytometric study of paraffin-embedded archival material. J Neurosurg 71: 341-351
16. Mahmood A, Caccamo DV, Tomecek FJ, et al (1993) Atypical and malignant meningiomas: A clinicopathological review. Neurosurgery 33: 955-963
17. Mirabell R, Linggog RM, de la Monte S, Convery K, Munzenrider JE, Mirimanotf RO (1992) The role of radiotherapy in the treatment of subtotally resected benign meningiomas. J Neurooncol 13: 157-164
18. Onda K, Davis RL, Wilson CB, Hoshino T (1994) Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas. Cancer 74: 1921-1926
19. Palsouris E, Stocker U, Kallmeyer V, Keiditsch E, Mehraein P, Stavrou D (1988) Relationship between Ki-67 positive cells, growth rate and histological type of human intracranial tumours. Anticancer Res 8: 537-544
20. Rasband W (1995) Analyze: menu. In: NIH Image, Ver. 1.59 Manual, pp 36-43
21. Roggendorf W, Schuster T, Pfeiffer J (1987) Proliferative potential of meningiomas determined with the monoclonal antibody Ki-67. Acta Neuropathol 73: 361-364
22. Sasaki A, Naganuma H, Kimura R, Isoe S, Nakano S, Nukui H, Suzuki K, Kawaoi A (1992) Poliferating cell nuclear antigen (PCNA) immunostaining as an alternative to bromodeoxyuridine (BrdU) immunostaining for brain tumours in paraffin embedded section. Acta Neurochir (Wien) 117: 178-181
23. Sasaki K, Matsumura K, Tsuji T, Shinozaki F, Takahashi M (1988) Relationship between labeling indices of Ki-67 and BrdUrd in human malignant tumours. Cancer 62: 989-993
24. Servo A, Jääskeläinen J, Paetau A, Haltia M (1990) Computed tomography and angiography do not reliably discriminate malignant meningiomas from benign ones. Neuroradiology 32 (2): 94-97
25. Thomas HG, Dolman CL, Berry K (1981) Malignant meningioma: clinical and pathological features. J Neurosurg 55: 929-934